Position in GMAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,014,291
+$3,757,070 QoQ
Shares Held
910,604
+14.9% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 292 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Derivatives in GMAB
reported options exposure · as of Dec 31, 2024CallValue
$2,673,447
CallShares
128,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. GMAB ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in GMAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,014,291 | 910,604 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,257,221 | 792,293 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,912,848 | 94,573 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,788,301 | 90,913 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,980,875 | 386,296 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,011,691 | 868,830 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $19,362,184 | 927,752 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $2,673,447 | 128,100 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $13,770,604 | 564,832 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,574,404 | 380,995 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,175,216 | 473,929 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,311,027 | 512,281 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,980,582 | 141,213 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $295,755 | 7,781 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,570,494 | 306,422 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $38,964,511 | 919,408 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,908,228 | 121,638 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $2,878,408 | 79,558 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,902,866 | 149,213 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,185,000 | 50,000 | Call | Sole | 2021-11-15 | |
| 2021-09-30 | $449,760 | 10,292 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $661,904 | 16,279 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,499,696 | 95,594 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $8,679,229 | 256,100 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $8,408,255 | 396,803 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||